CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $697,937
- in 4 filings, $698K under 10b5-1 plans
Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-16 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Exercise or conversion | +3,375 | 210,720 | ||
| 2021-02-16 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Shares withheld for taxes | −1,678 | $19.79 | $33K | 209,042 |
| 2021-02-16 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Exercise or conversion · Restricted Stock Unit Award | −3,375 | 3,375 | ||
| 2021-02-16 | Jackson Blair Curtis EVP, Chief Operating Officer | Exercise or conversion | +2,375 | 60,907 | ||
| 2021-02-16 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −825 | $19.79 | $16K | 60,082 |
| 2021-02-16 | Jackson Blair Curtis EVP, Chief Operating Officer | Exercise or conversion · Restricted Stock Unit Award | −2,375 | 2,375 | ||
| 2021-02-16 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Exercise or conversion | +3,375 | 18,208 | ||
| 2021-02-16 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −1,172 | $19.79 | $23K | 17,036 |
| 2021-02-16 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Exercise or conversion · Restricted Stock Unit Award | −3,375 | 3,375 | ||
| 2021-02-16 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Exercise or conversion | +3,375 | 64,309 | ||
| 2021-02-16 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −1,172 | $19.79 | $23K | 63,137 |
| 2021-02-16 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Exercise or conversion · Restricted Stock Unit Award | −3,375 | 3,375 | ||
| 2021-02-16 | Brown Iain Michael SVP, Chief Financial Officer | Exercise or conversion | +2,375 | 40,956 | ||
| 2021-02-16 | Brown Iain Michael SVP, Chief Financial Officer | Shares withheld for taxes | −825 | $19.79 | $16K | 40,131 |
| 2021-02-16 | Brown Iain Michael SVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Unit Award | −2,375 | 2,375 | ||
| 2021-02-10 | Daglio David Angelo Jr. Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +26,169 | 26,169 | ||
| 2021-02-10 | Daglio David Angelo Jr. Director | Grant or award · Restricted Stock Unit Award | +13,336 | 13,336 | ||
| 2021-02-10 | Daglio David Angelo Jr. Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +4,549 | 4,549 | ||
| 2021-02-10 | Daglio David Angelo Jr. Director | Grant or award · Restricted Stock Unit Award | +2,223 | 2,223 | ||
| 2021-02-10 | MCKEON BRIAN P Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +26,169 | 26,169 |
Page 69 of 75 · 1,492 trades